New Multiple Sclerosis drug, backed by 40 years of research, could halt disease

CDC: Hepatitis C cases reach 15-year high
June 22, 2017
Johnson & Johnson commits $990M to land Protagonist’s oral Crohn’s drug
June 22, 2017
Show all

New Multiple Sclerosis drug, backed by 40 years of research, could halt disease

Comments are closed.